Drugs / EMIPLACEL
Trials 11
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT01795950 | Apr 2013 → Dec 2015 | pulmonary arterial hypertension | United Therapeutics | Terminated | No outcome recorded |
| Phase 1 | NCT00951210 | Aug 2009 → Jan 2011 | limb ischemia, peripheral arterial disease | Pluristem Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT00919958 | Jun 2009 → Jun 2012 | limb ischemia, peripheral arterial disease | Pluristem Ltd. | Completed | No outcome recorded |
| Phase 1/21 trial · 1 met primary | ||||||
| Phase 1/2 | NCT01525667 | Nov 2012 → Dec 2013 | — | Pluristem Ltd. | Completed | Met primary |
| Phase 23 trials | ||||||
| Phase 2 | NCT04614025 | Oct 2020 → Aug 2021 | COVID-19, acute respiratory distress syndrome | Pluristem Ltd. | Terminated | No outcome recorded |
| Phase 2 | NCT04389450 | Oct 2020 → May 2021 | COVID-19, acute respiratory distress syndrome | Pluristem Ltd. | Terminated | No outcome recorded |
| Phase 2 | NCT01679990 | Nov 2012 → Mar 2018 | intermittent vascular claudication, peripheral arterial disease | Pluristem Ltd. | Completed | No outcome recorded |
| Phase 32 trials · 1 missed | ||||||
| Phase 3 | NCT03451916 | Jul 2018 → Apr 2022 | — | Pluristem Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT03006770 | May 2017 → Mar 2021 | limb ischemia | Pluristem Ltd. | Completed | Missed primary |
| Phase not stated2 trials | ||||||
| — | NCT03886506 | — | limb ischemia | Pluristem Ltd. | No longer available | No outcome recorded |
| — | NCT03746899 | — | limb ischemia | WideTrial, Inc. | Available | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMIPLACEL | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297243 ↗ |
| Known as | PLX-PAD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00919958 ↗ |
| Modality | Cell therapy | “PLX-PAD are mesenchymal-like stromal cells derived from a full term placenta” NCT00919958 ↗ |
| Route | Intramuscular | “Intramuscular (IM) Injection” NCT00919958 ↗ |